Clinical Trial Update: Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of lemborexant on insomnia and its relationship to mood and behavior in individuals with opioid use disorder; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Opioid Use Disorder

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Opioid Use Disorder, Opioid Use | Phase 2 | Status: RECRUITING